Active Ingredient: ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE
Proprietary Name: XARTEMIS XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N204031
Product Number: 001
Approval Date: Mar 11, 2014
Applicant Holder Full Name: MALLINCKRODT INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
